Accéder à l'en-tête Accéder au contenu principal Accéder au pied de page
Back
  • News
07/05/2023

Acquisition of the Newton 7.0 Bioluminescence imaging system

in vivo imaging is available at TransCure bioServices

Equipped with the Newton 7.0 Bioluminescence imaging system, we can monitor, in a living animal, orthotopic, metastatic dissemination and subcutaneous tumor progression.

The NEWTON bioluminescence imaging system allows for the non-invasive detection and quantification from the onset throughout full development of any tumor.

Talk to us for more information.

See our other news and events

    • News

    07/03/2025

    New Partnership: TransCure bioServices and Preclina Inc Join Forces to Expand Collaboration

    • News

    07/02/2025

    What Can We Do For You: New CDX Models for AML Studies

    • News

    07/01/2025

    TransCure bioServices Improves Its Services with 3D Tumor Imaging from Biovolume